Assessing the impact of acute respiratory failure in Chinese ICUs
A Multicentre, Prospective, Observational, 8-week Inception Cohort Study Being Carried Out by the Acute Respiratory Failure Section of China
This study looks at how common acute respiratory failure is in Chinese ICUs during winter and tries to see how well different treatments work for patients who need help breathing.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Southeast University, China Academic / other |
| Locations | 2 sites (Beijin and 1 other locations) |
| Trial ID | NCT06213779 on ClinicalTrials.gov |
What this trial studies
This observational study aims to prospectively evaluate the burden and management of acute respiratory failure and acute respiratory distress syndrome (ARDS) in Chinese ICUs during the winter months. It will collect data on the frequency, incidence, mortality, and long-term outcomes of ARDS, as well as the effectiveness of various respiratory support strategies and medications used in ICU settings. The study will involve multiple ICUs across China, recruiting patients who require respiratory support. The findings are expected to provide valuable insights into the disease burden and treatment approaches for acute respiratory failure in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 18 and older who are admitted to ICUs and require invasive or non-invasive ventilation.
Not a fit: Patients under 18 years of age will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could enhance understanding of acute respiratory failure and improve management strategies, ultimately leading to better patient outcomes.
How similar studies have performed: While this study focuses on a specific national cohort, similar observational studies have successfully provided insights into ARDS management and outcomes in other regions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients admitted to the participating ICU receiving invasive, non-invasive ventilation or high-flow nasal cannula (HFNC) will be screened and included in the database. Exclusion Criteria: * Age\<18.
Where this trial is running
Beijin and 1 other locations
- China-Japan friendship hospital — Beijin, China (Recruiting)
- Zhongda Hospital, Southeast university — Nanjing, China (Recruiting)
Study contacts
- Study coordinator: Ling Liu, PhD
- Email: liulingdoctor@126.com
- Phone: +86-02583262550
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.